Physician profile
William Casale
NPI 1588753339
$936.77
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $200 · 2021: $115 · 2022: $96.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $369.37 | 2019-2021 | |
| Astellas Pharma US INC | $195.32 | 2019-2022 | |
| Therapeuticsmd, INC. | $132.15 | 2019 | |
| Radius Health, INC. | $72.51 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $49.82 | 2019 | |
| Pfizer INC. | $42.04 | 2021-2022 | |
| Allergan, INC. | $30.64 | 2019 | |
| Zyla Life Sciences, INC. | $28.87 | 2020 | |
| Abbvie INC. | $16.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Casale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.